Document 0013 DOCN M95B0013 TI Vaccine strategies: targeting helper T cell responses. DT 9511 AU Golding B; Scott DE; Laboratory of Plasma Derivatives, United States Food and Drug; Administration, Bethesda, Maryland 20892, USA. SO Ann N Y Acad Sci. 1995 May 31;754:126-37. Unique Identifier : AIDSLINE MED/95351594 AB Vaccine strategies need to take into account the balance of T helper subsets they induce. TH1 cells, which secrete IFN gamma and IL-2, are associated with CMI, rather than humoral responses, and afford protection against intracellular infections including parasites. In contrast, TH2 cells secrete IL-4, IL-5, and IL-10; elicit high-titer antibody responses and poor CMI; and are associated with susceptibility to infection with intracellular pathogens. Depending on the type of TH cell bias required, it is possible to manipulate the immune response to a protein or peptide by employing (1) different adjuvants, (2) conjugating the protein to various carriers, (3) immunizing in the presence of cytokines, (4) using alternative routes of administration, or (5) using different forms or doses of antigen. To apply these approaches to a particular vaccine, it is necessary to identify which component of the infectious agent (e.g., envelope protein or peptide) or allergen to target. Once the type of TH cell response that is protective is identified, it may be possible to combine a protein with an adjuvant or link it to a carrier that will promote responses towards the most advantageous TH subset. DE Adjuvants, Immunologic Animal Antigens/IMMUNOLOGY Cytokines/IMMUNOLOGY Dose-Response Relationship, Immunologic Drug Administration Routes Human Immunity, Cellular T-Lymphocyte Subsets/*IMMUNOLOGY Th1 Cells/*IMMUNOLOGY Th2 Cells/*IMMUNOLOGY Vaccines/ADMINISTRATION & DOSAGE/*IMMUNOLOGY Vaccines, Conjugate/IMMUNOLOGY JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).